Inactive Instrument

Press Releases Renovacor, Inc.

Equities

RCOR

US75989E1064

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - OFIX, LMST, PFHD, RCOR	22-11-17	PR
RENOVACOR, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-11-10	AQ
RENOVACOR, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-10-14	AQ
Renovacor Announces Upcoming Presentation at the 29th European Society of Gene and Cell Therapy Congress	22-10-11	AQ
Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress	22-10-10	BU
Renovacor Announces Upcoming Presentation at Keystone Symposia's Heart Failure, Mechanisms and Therapies Conference	22-09-27	AQ
Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference	22-09-26	BU
RENOVACOR, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-09-22	AQ
Shareholder Alert: Ademi LLP investigates whether Renovacor, Inc. has obtained a Fair Price in its transaction with Rocket Pharmaceuticals, Inc.	22-09-21	PR
RENOVACOR, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	22-09-20	AQ
SHAREHOLDER ALERT: Weiss Law Investigates Renovacor, Inc.	22-09-20	PR
RCOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Renovacor, Inc. Is Fair to Shareholders	22-09-20	BU
Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy	22-09-20	BU
Renovacor : Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Form 8-K	22-08-08	PU
RENOVACOR, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-08-08	AQ
Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update	22-08-08	BU
RENOVACOR, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	22-08-08	AQ
RENOVACOR, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-07-12	AQ
Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy	22-07-12	BU
RENOVACOR, INC. Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K/A)	22-06-24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Renovacor, Inc.

Equities

RCOR

US75989E1064

Press Releases

Filters